#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anti-myelin-associated glycoprotein associated polyneuropathy Behcet's syndrome Cystic fibrosis IgA nephropathy Nephrotic syndrome Pulmonary fibrosis Cardiac failure acute Fallopian tube cancer Oesophageal adenocarcinoma Cutaneous T-cell lymphoma stage II Myotonic dystrophy B-cell lymphoma Tuberous sclerosis complex Epstein-Barr virus associated lymphoproliferative disorder Lymphangioma More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Diagnostics Chordoma Cystic fibrosis – Life with Disease Niemann-Pick disease – Life with Disease Hepatic angiosarcoma – Diagnostics Gaucher’s disease type I – Diagnostics Erdheim-Chester disease – Trials in Disease Angelman’s syndrome – Treatment Acute respiratory distress syndrome – Basic Information Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Galunisertib Bepirovirsen ALXN1920 Terlipressin Acetate Relugolix Crd-4730 Estradiol ADX-324 Clebopride Hydrogen Maleate Osilodrostat Clarithromycin Rasagiline 534 Quinapril Hydrochloride Lasn01 Df6002 Trospium Chloride Bicalutamide Gen3017 Blu-222 More therapies…

    Learn about Your Condition

    Pituitary tumour benign Strongyloidiasis Vulvovaginal pruritus Migraine with aura Thalassaemia beta Follicular thyroid cancer Hyperchylomicronaemia Richter's syndrome Migraine without aura Craniocerebral injury Synovial sarcoma recurrent Tourette's disorder Retinopathy of prematurity Haemorrhage prophylaxis Immune thrombocytopenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Long-Term Safety and Efficacy of VX-670 for Adults with Myotonic Dystrophy Type I

    Recruiting

    1 1 1
    Investigated Drugs:
    • Vx-670
    Belgium France Germany Italy The Netherlands Spain

  • Study on the Safety of Using Autologous Stromal Vascular Fraction Cells and Micrograft for Treating Hard-to-Heal Ano-Perineal Fistulas in Crohn’s Disease Patients

    Recruiting

    2 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Autologous Adipose Tissue-Derived Stromal Vascular Fraction Cells
    France

  • Study on Doxycycline for Reducing Bacterial STIs in MSM and TGW with HIV

    Recruiting

    3 1 1
    Investigated Drugs:
    • Doxycycline Monohydrate
    Belgium

  • Study of Omecamtiv Mecarbil for Treating Patients with Chronic Heart Failure and Severely Reduced Heart Pumping Ability

    Recruiting

    3 1
    Investigated Drugs:
    • OMECAMTIV MECARBIL
    France Germany Greece Italy Poland Spain

  • Study comparing NVL-655 to alectinib in untreated patients with ALK-positive advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Nvl-655
    • Alectinib Hydrochloride
    Austria Belgium Czechia Denmark France Germany +7

  • Comparison of TAK-881 and HyQvia for adults with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Hyaluronidase (Human Recombinant)
    • Human Normal Immunoglobulin
    Czechia Denmark Germany Greece Italy Poland +2
Previous Page
1 … 205 206 207 208 209 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!